Neurocrine Biosciences, Inc. (NBIX) Social Stream



Neurocrine Biosciences, Inc. (NBIX): $108.25

-0.13 (-0.12%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

NEUROCRINE BIOSCIENCES INC (NBIX) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering NEUROCRINE BIOSCIENCES INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-03 20 $150 $100 $123.5 $108.8 13.51%
2021-11-17 20 $150 $100 $123.222 $108.8 13.26%
2021-11-19 20 $150 $76 $120.736 $108.8 10.97%
2021-12-07 21 $150 $76 $120.736 $108.8 10.97%
2022-01-07 22 $154 $76 $122 $108.8 12.13%
2022-01-10 22 $154 $76 $121.789 $108.8 11.94%
2022-01-18 22 $154 $76 $120.263 $108.8 10.54%
2022-01-26 22 $154 $76 $119.052 $108.8 9.42%
2022-01-30 22 $154 $76 $117.157 $108.8 7.68%
2022-01-31 22 $154 $76 $116.736 $108.8 7.29%
2022-02-14 21 $154 $76 $116.473 $108.8 7.05%
2022-02-16 21 $150 $76 $116.473 $108.8 7.05%
2022-02-25 21 $150 $76 $115.65 $108.8 6.3%
2022-03-03 21 $150 $76 $114.6 $108.8 5.33%
2022-04-12 20 $150 $76 $114.65 $108.8 5.38%
2022-04-21 19 $150 $76 $114.55 $108.8 5.28%
2022-05-04 20 $150 $76 $114.8 $108.8 5.51%
2022-05-05 20 $150 $76 $114.6 $108.8 5.33%
2022-05-06 19 $150 $76 $114.4 $108.8 5.15%
2022-05-10 19 $150 $76 $114.368 $108.8 5.12%
2022-06-02 19 $150 $76 $114.315 $108.8 5.07%
2022-06-06 19 $150 $76 $113.578 $108.8 4.39%
2022-08-01 19 $150 $76 $113.736 $108.8 4.54%
2022-08-05 20 $150 $76 $114.052 $108.8 4.83%
2022-08-13 20 $150 $76 $114.5 $108.8 5.24%
2022-08-18 20 $150 $76 $114.9 $108.8 5.61%
2022-09-21 20 $150 $76 $115.55 $108.8 6.2%
2022-09-26 20 $150 $76 $115.285 $108.8 5.96%
2022-10-11 21 $150 $76 $116.227 $108.8 6.83%
2022-10-13 21 $150 $76 $116.818 $108.8 7.37%
2022-10-20 22 $150 $76 $116.304 $108.8 6.9%
2022-10-21 22 $150 $76 $116.347 $108.8 6.94%
2022-10-24 21 $150 $76 $116.608 $108.8 7.18%
2022-11-02 21 $150 $91 $121.478 $108.8 11.65%
2022-11-03 21 $150 $101 $125.391 $108.8 15.25%
2022-11-14 22 $150 $101 $126.043 $108.8 15.85%
2023-01-17 21 $150 $101 $126.043 $108.8 15.85%
2023-01-23 21 $150 $101 $126.13 $108.8 15.93%

The Trend in the Analyst Price Target


NBIX's average price target has moved down $1.92 over the prior 22 months.

NBIX reports an average of 22.75% for its upside potential over the past 52 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-02-14 21 150 76 116.421 86.52 34.56%
2022-02-16 21 150 76 116.473 85.87 35.64%
2022-03-03 20 150 76 114.600 87.62 30.79%
2022-05-06 19 150 76 114.368 79.55 43.77%
2022-09-10 20 150 76 115.550 106.51 8.49%

NBIX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.71 13 1 7 0 0 21

The Trend in the Broker Recommendations


Over the past 52 weeks, NBIX's average broker recommendation rating improved by 0.06.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • To contextualize these metrics, consider that out of all US stocks, NEUROCRINE BIOSCIENCES INC's number of analysts covering the stock is higher than 4672.27% of them.
  • In terms of how NEUROCRINE BIOSCIENCES INC fares relative to Pharmaceutical Products stocks, note that its average analyst price target is greater than 4306.88% of that group.
  • In the context of Pharmaceutical Products stocks, NEUROCRINE BIOSCIENCES INC's upside potential (average analyst target price relative to current price) is greater than 620.05% of them.
  • NBIX has a lower variance in analysts' estimates than -3273.03% of stocks in the large market cap category.

In the Pharmaceutical Products industry, GILD, BIIB, and TECH are the three stocks most similar to NEUROCRINE BIOSCIENCES INC regarding the price target and analyst recommendation information presented here.

Make investment decisions regarding NBIX using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6715 seconds.